Login Register Cart 0
Generic placeholder image

Current Drug Research Reviews

Editor-in-Chief

ISSN (Print): 2589-9775
ISSN (Online): 2589-9783

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Review Article

Biological Potential of Kakkalide in Medicine for the Treatment of Human Disorders: An Overview of Pharmacological Aspects

Author(s): Dinesh Kumar Patel* and Kanika Patel

Volume 16, Issue 2, 2024

Published on: 18 September, 2023

Page: [157 - 163] Pages: 7

DOI: 10.2174/2589977515666230824152740

Price: $65

Abstract

Background: Pueraria lobata is an important herbal medicine of Fabaceae family that has been clinically used in Traditional Chinese Medicine to counteract human disorders and associated secondary complications. Kakkalide also called irisolidone 7-xylosylglucoside is an isoflavonoid of Puerariae flos, Pueraria lobata and Flos Puerariae. Moreover, Kakkalide has a wide range of bioactivities in medicine.

Methods: Biological potential of kakkalide was investigated in the present work through scientific data analysis of different scientific research work on kakkalide in order to know its therapeutic potential in medicine. Scientific data on Pueraria lobata were collected and analyzed in the present work. All the scientific data were collected from Google, Google Scholar, Scopus, and Science Direct in the present work.

Results: Scientific data analysis of kakkalide revealed its biological importance and therapeutic potential in medicine. The present investigation signified kakkalide’s effectiveness in inflammatory diseases, prostaglandin E2 production, liver complication, gastric injury, alcoholism, insulinresistant endothelial dysfunction, aldose reductase enzyme, hyperlipidemia, estrogenic activity, and stroke. In addition, the bioavailability of kakkalide was also discussed in the present paper. Present work also revealed the significance of analytical techniques for the separation, isolation and identification of kakkalide in different biological and non-biological samples.

Conclusion: Present paper signified the health-beneficial aspects of kakkalide in medicine.

« Previous Next »
Graphical Abstract

[1]
Boy HIA, Rutilla AJH, Santos KA, et al. Recommended medicinal plants as source of natural products: A review. Dig Chinese Med 2018; 1(2): 131-42.
[http://dx.doi.org/10.1016/S2589-3777(19)30018-7]
[2]
Mashour NH, Lin GI, Frishman WH. Herbal medicine for the treatment of cardiovascular disease: clinical considerations. Arch Intern Med 1998; 158(20): 2225-34.
[http://dx.doi.org/10.1001/archinte.158.20.2225] [PMID: 9818802]
[3]
da Silva FMA, da Silva KPA, de Oliveira LPM, et al. Flavonoid glycosides and their putative human metabolites as potential inhibitors of the SARS-CoV-2 main protease (Mpro) and RNA-dependent RNA polymerase (RdRp). Mem Inst Oswaldo Cruz 2020; 115e200207
[http://dx.doi.org/10.1590/0074-02760200207] [PMID: 33027419]
[4]
Liu Y, Zhou JL, Liu P, Sun S, Li P. Chemical markers’ fishing and knockout for holistic activity and interaction evaluation of the components in herbal medicines. J Chromatogr A 2010; 1217(32): 5239-45.
[http://dx.doi.org/10.1016/j.chroma.2010.06.039] [PMID: 20619417]
[5]
Patel DK, Patel K. Potential therapeutic applications of eudesmin in medicine: An overview on medicinal importance, pharmacological activities and analytical prospects. Pharmacol Res - Mod Chinese Med 2022; 5100175
[http://dx.doi.org/10.1016/j.prmcm.2022.100175]
[6]
Patel DK. Pharmacological activities and therapeutic potential of kaempferitrin in medicine for the treatment of human disorders: a review of medicinal importance and health benefits. Cardiovasc Hematol Disord Drug Targets 2021; 21(2): 104-14.
[http://dx.doi.org/10.2174/1871529X21666210812111931] [PMID: 34387174]
[7]
Kiyohara H, Matsumoto T, Nagai T, Kim SJ, Yamada H. The presence of natural human antibodies reactive against pharmacologically active pectic polysaccharides from herbal medicines. Phytomedicine 2006; 13(7): 494-500.
[http://dx.doi.org/10.1016/j.phymed.2005.09.004] [PMID: 16427263]
[8]
Leung ELH, Wu QB. Concurrent use of herbal products with prescription drugs is a double-edged sword and evidence-based medicine contributes to reshaping the practice. Pharmacol Res 2019; 141: 609-10.
[http://dx.doi.org/10.1016/j.phrs.2019.01.033] [PMID: 30660823]
[9]
Patel DK. Biological potential and therapeutic benefit of Chrysosplenetin: An Applications of polymethoxylated flavonoid in medicine from natural sources. Pharmacol Res - Mod Chinese Med 2022; 4100155
[http://dx.doi.org/10.1016/j.prmcm.2022.100155]
[10]
Patel K, Gadewar M, Tahilyani V, Patel DK. A review on pharmacological and analytical aspects of diosmetin: A concise report. Chin J Integr Med 2013; 19(10): 792-800.
[http://dx.doi.org/10.1007/s11655-013-1595-3] [PMID: 24092244]
[11]
Patel DK, Patel K. Health benefits of avicularin in the medicine against cancerous disorders and other complications: biological importance, therapeutic benefit and analytical aspects. Curr Cancer Ther Rev 2022; 18(1): 41-50.
[http://dx.doi.org/10.2174/1573394717666210831163322]
[12]
Crone CC, Wise TN. Use of herbal medicines among consultation-liaison populations. A review of current information regarding risks, interactions, and efficacy. Psychosomatics 1998; 39(1): 3-13.
[http://dx.doi.org/10.1016/S0033-3182(98)71374-X] [PMID: 9538669]
[13]
Patel K, Singh GK, Patel DK. A review on pharmacological and analytical aspects of naringenin. Chin J Integr Med 2018; 24(7): 551-60.
[http://dx.doi.org/10.1007/s11655-014-1960-x] [PMID: 25501296]
[14]
Patel K, Patel DK. Secoiridoid amarogentin from ‘gentianaceae’ with their health promotion, disease prevention and modern analytical aspects. Curr Bioact Compd 2020; 16(3): 191-200.
[http://dx.doi.org/10.2174/1573407214666181023115355]
[15]
Takahashi N, Kawada T, Goto T, et al. Dual action of isoprenols from herbal medicines on both PPARγ and PPARα in 3T3-L1 adipocytes and HepG2 hepatocytes. FEBS Lett 2002; 514(2-3): 315-22.
[http://dx.doi.org/10.1016/S0014-5793(02)02390-6] [PMID: 11943173]
[16]
Liperoti R, Vetrano DL, Bernabei R, Onder G. Herbal medications in cardiovascular medicine. J Am Coll Cardiol 2017; 69(9): 1188-99.
[http://dx.doi.org/10.1016/j.jacc.2016.11.078] [PMID: 28254182]
[17]
Choudhury H, Pandey M, Hua CK, et al. An update on natural compounds in the remedy of diabetes mellitus: A systematic review. J Tradit Complement Med 2018; 8(3): 361-76.
[http://dx.doi.org/10.1016/j.jtcme.2017.08.012] [PMID: 29992107]
[18]
Ota A, Ulrih NP. An overview of herbal products and secondary metabolites used for management of type two diabetes. Front Pharmacol 2017; 8: 436.
[http://dx.doi.org/10.3389/fphar.2017.00436] [PMID: 28729836]
[19]
Gomez MR, Cerutti S, Sombra LL, Silva MF, Martínez LD. Determination of heavy metals for the quality control in argentinian herbal medicines by ETAAS and ICP-OES. Food Chem Toxicol 2007; 45(6): 1060-4.
[http://dx.doi.org/10.1016/j.fct.2006.12.013] [PMID: 17291663]
[20]
Patel K, Kumar V, Verma A, Rahman M, Kumar Patel D. Health benefits of furanocoumarins ‘psoralidin’ an active phytochemical of psoralea corylifolia: the present, past and future scenario. Curr Bioact Compd 2019; 15(4): 369-76.
[http://dx.doi.org/10.2174/1573407214666180511153438]
[21]
Patel DK. Biological importance of a biflavonoid ‘bilobetin’ in the medicine: medicinal importance, pharmacological activities and analytical aspects. Infect Disord Drug Targets 2022; 22(5): 22-30.
[PMID: 35319397]
[22]
Patel K, Kumar V, Rahman M, Verma A, Patel DK. Rhamnazin: A systematic review on ethnopharmacology, pharmacology and analytical aspects of an important phytomedicine. Curr Tradit Med 2018; 4(2): 120-7.
[http://dx.doi.org/10.2174/2215083804666180416124949]
[23]
Tag H, Kalita P, Dwivedi P, Das AK, Namsa ND. Herbal medicines used in the treatment of diabetes mellitus in Arunachal Himalaya, northeast, India. J Ethnopharmacol 2012; 141(3): 786-95.
[http://dx.doi.org/10.1016/j.jep.2012.03.007] [PMID: 22433536]
[24]
Kamagaju L, Morandini R, Bizuru E, et al. Tyrosinase modulation by five Rwandese herbal medicines traditionally used for skin treatment. J Ethnopharmacol 2013; 146(3): 824-34.
[http://dx.doi.org/10.1016/j.jep.2013.02.010] [PMID: 23439030]
[25]
Calixto JB. Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Braz J Med Biol Res 2000; 33(2): 179-89.
[http://dx.doi.org/10.1590/S0100-879X2000000200004] [PMID: 10657057]
[26]
Karunamoorthi K, Jegajeevanram K, Vijayalakshmi J, Mengistie E. Traditional medicinal plants. J Evid Based Compl Altern Med 2013; 18(1): 67-74.
[http://dx.doi.org/10.1177/2156587212460241]
[27]
Xu JD, Wu J, Zhou SS, et al. High performance liquid chromatography–electrospray ionization-mass spectrometry with programmed ionization mode switching and time segment scanning approach for quantifying multi-components in traditional complex herbal medicines, Qiong-Yu-Gao as an example. J Pharm Biomed Anal 2015; 112: 139-46.
[http://dx.doi.org/10.1016/j.jpba.2015.04.015] [PMID: 25982197]
[28]
Mwangi VI, Mumo RM, Nyachieo A, Onkoba N. Herbal medicine in the treatment of poverty associated parasitic diseases: A case of sub-Saharan Africa. J Herb Med 2017; 10: 1-7.
[http://dx.doi.org/10.1016/j.hermed.2017.03.002]
[29]
Verma S, Singh S. Current and future status of herbal medicines. Vet World 2008; 2(2): 347.
[http://dx.doi.org/10.5455/vetworld.2008.347-350]
[30]
Alves RRN, Rosa IML. Biodiversity, traditional medicine and public health: where do they meet? J Ethnobiol Ethnomed 2007; 3(1): 14.
[http://dx.doi.org/10.1186/1746-4269-3-14] [PMID: 17376227]
[31]
Singh V, Al-Malki F, Sadat Ali M, et al. Rhus aucheri Boiss, an Omani herbal medicine: Identification and in-vitro antioxidant and antibacterial potentials of its leaves’ extracts. Beni Suef Univ J Basic Appl Sci 2016; 5(4): 334-9.
[http://dx.doi.org/10.1016/j.bjbas.2016.11.002]
[32]
Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 2014; 4: 177.
[http://dx.doi.org/10.3389/fphar.2013.00177] [PMID: 24454289]
[33]
Sen S, Chakraborty R. Toward the integration and advancement of herbal medicine: a focus on traditional Indian medicine. Bot Targets Ther 2015; p. 33.
[34]
Pan SY, Zhou SF, Gao SH, et al. New perspectives on how to discover drugs from herbal medicines: CAM’s outstanding contribution to modern therapeutics. Evid Based Complement Alternat Med 2013; 2013: 1-25.
[http://dx.doi.org/10.1155/2013/627375] [PMID: 23634172]
[35]
Liu Z, Chen S, Cai J, et al. Traditional Chinese Medicine syndrome-related herbal prescriptions in treatment of malignant tumors. J Tradit Chin Med 2013; 33(1): 19-26.
[http://dx.doi.org/10.1016/S0254-6272(13)60095-3] [PMID: 23596807]
[36]
Shin J, Bae EA, Lee YC, Ma JY, Kim DH. Estrogenic effect of main components kakkalide and tectoridin of Puerariae Flos and their metabolites. Biol Pharm Bull 2006; 29(6): 1202-6.
[http://dx.doi.org/10.1248/bpb.29.1202] [PMID: 16755017]
[37]
Tungmunnithum D, Intharuksa A, Sasaki Y. A Promising View of Kudzu Plant, Pueraria montana var. lobata (Willd.) Sanjappa; Pradeep: Flavonoid Phytochemical Compounds, Taxonomic Data, Traditional Uses and Potential Biological Activities for Future Cosmetic Application. Cosmetics 2020; 7(1): 12.
[http://dx.doi.org/10.3390/cosmetics7010012]
[38]
Jang HM, Park KT, Noh HD, Lee SH, Kim DH. Kakkalide and irisolidone alleviate 2,4,6-trinitrobenzenesulfonic acid-induced colitis in mice by inhibiting lipopolysaccharide binding to toll-like receptor-4 and proteobacteria population. Int Immunopharmacol 2019; 73: 246-53.
[http://dx.doi.org/10.1016/j.intimp.2019.05.008] [PMID: 31112869]
[39]
Yao M, Liao Y, Li GQ, Law FCP, Tang Y. Quantitative analysis of two isoflavones in Pueraria lobata flowers from eleven Chinese provinces using high performance liquid chromatography. Chin Med 2010; 5(1): 14.
[http://dx.doi.org/10.1186/1749-8546-5-14] [PMID: 20416072]
[40]
Niiho Y, Nakajima Y, Yamazaki T, et al. Simultaneous analysis of isoflavones and saponins in Pueraria flowers using HPLC coupled to an evaporative light scattering detector and isolation of a new isoflavone diglucoside. J Nat Med 2010; 64(3): 313-20.
[http://dx.doi.org/10.1007/s11418-010-0411-z] [PMID: 20354803]
[41]
Chen C, Li X, Kano Y, Yuan D, Qu J. Oriental traditional herbal Medicine——Puerariae Flos: A systematic review. J Ethnopharmacol 2023; 306116089
[http://dx.doi.org/10.1016/j.jep.2022.116089] [PMID: 36621660]
[42]
Chen X, Zhang J, Li R, et al. Flos Puerariae-Semen Hoveniae medicinal pair extract ameliorates DSS-induced inflammatory bowel disease through regulating MAPK signaling and modulating gut microbiota composition. Front Pharmacol 2022; 131034031
[http://dx.doi.org/10.3389/fphar.2022.1034031] [PMID: 36569313]
[43]
Zhang D, Gao X, Wang Q, et al. Kakkalide ameliorates endothelial insulin resistance by suppressing reactive oxygen species-associated inflammation. J Diabetes 2013; 5(1): 13-24.
[http://dx.doi.org/10.1111/1753-0407.12017] [PMID: 23190749]
[44]
Yuan D, Xie YY, Bai X, Wu X, Yang JY, Wu CF. Inhibitory activity of isoflavones of Pueraria flowers on nitric oxide production from lipopolysaccharide-activated primary rat microglia. J Asian Nat Prod Res 2009; 11(6): 471-81.
[http://dx.doi.org/10.1080/10286020902819822] [PMID: 20183278]
[45]
Min SW, Park YJ, Kim DH. Kakkalide and its metabolite irisolidone ameliorate carrageenan-induced inflammation in mice by inhibiting NF-κB pathway. Inflammation 2011; 34(5): 344-51.
[http://dx.doi.org/10.1007/s10753-010-9240-1] [PMID: 20686830]
[46]
Bai X, Xie Y, Liu J, Qu J, Kano Y, Yuan D. Isolation and identification of urinary metabolites of kakkalide in rats. Drug Metab Dispos 2010; 38(2): 281-6.
[http://dx.doi.org/10.1124/dmd.109.028555] [PMID: 19910516]
[47]
Lee HU, Bae EA, Kim DH. Hepatoprotective effects of irisolidone on tert-butyl hyperoxide-induced liver injury. Biol Pharm Bull 2005; 28(3): 531-3.
[http://dx.doi.org/10.1248/bpb.28.531] [PMID: 15744084]
[48]
Zhang G, Gong T, Kano Y, Yuan D. Screening for in vitro metabolites of kakkalide and irisolidone in human and rat intestinal bacteria by ultra-high performance liquid chromatography/quadrupole time-of-flight mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2014; 947-948: 117-24.
[http://dx.doi.org/10.1016/j.jchromb.2013.12.017] [PMID: 24412694]
[49]
Kim C, Shin S, Ha H, Kim JM. study of substance changes in flowers of pueraria thunbergiana benth. during storage. Arch Pharm Res 2003; 26(3): 210-3.
[http://dx.doi.org/10.1007/BF02976832] [PMID: 12723934]
[50]
Park JS, Woo MS, Kim DH, et al. Anti-inflammatory mechanisms of isoflavone metabolites in lipopolysaccharide-stimulated microglial cells. J Pharmacol Exp Ther 2007; 320(3): 1237-45.
[http://dx.doi.org/10.1124/jpet.106.114322] [PMID: 17194798]
[51]
Yamazaki T, Nakajima Y, Niiho Y, et al. Pharmacological studies on Puerariae flos III: protective effects of kakkalide on ethanol-induced lethality and acute hepatic injury in mice. J Pharm Pharmacol 2011; 49(8): 831-3.
[http://dx.doi.org/10.1111/j.2042-7158.1997.tb06122.x] [PMID: 9379366]
[52]
Han YO, Han MJ, Park SH, Kim DH. Protective effects of kakkalide from Flos puerariae on ethanol-induced lethality and hepatic injury are dependent on its biotransformation by human intestinal microflora. J Pharmacol Sci 2003; 93(3): 331-6.
[http://dx.doi.org/10.1254/jphs.93.331] [PMID: 14646251]
[53]
Kang GD, Lee SY, Jang SE, Han MJ, Kim DH. Irisolidone attenuates ethanol-induced gastric injury in mice by inhibiting the infiltration of neutrophils. Mol Nutr Food Res 2017; 61(2)1600517
[http://dx.doi.org/10.1002/mnfr.201600517] [PMID: 27546737]
[54]
Chung IM, Kim MY, Park WH, Moon HI. Aldose reductase inhibitors from Viola hondoensis W. Becker et H Boss. Am J Chin Med 2008; 36(4): 799-803.
[http://dx.doi.org/10.1142/S0192415X08006247] [PMID: 18711775]
[55]
Min SW, Kim DH. Kakkalide and irisolidone: HMG-CoA reductase inhibitors isolated from the flower of Pueraria thunbergiana. Biol Pharm Bull 2007; 30(10): 1965-8.
[http://dx.doi.org/10.1248/bpb.30.1965] [PMID: 17917273]
[56]
Kang KA, Zhang R, Piao MJ, et al. Protective effect of irisolidone, a metabolite of kakkalide, against hydrogen peroxide induced cell damage via antioxidant effect. Bioorg Med Chem 2008; 16(3): 1133-41.
[http://dx.doi.org/10.1016/j.bmc.2007.10.085] [PMID: 17996449]
[57]
Cheng FY, Jing W, Hui J, Zhou L. Primary studies on chemical constituents from butanol extraction of the thorny elaeagnus leaf and their cytotoxicity. J Chinese Med Mater 2009; 32(12): 1848-50.
[58]
Li S, Li S, Liu C, Liu C, Zhang Y. Extraction and isolation of potential anti-stroke compounds from flowers of Pueraria lobata guided by in vitro PC12 cell model. J Chromatogr B Analyt Technol Biomed Life Sci 2017; 1048: 111-20.
[http://dx.doi.org/10.1016/j.jchromb.2017.02.009] [PMID: 28236683]
[59]
Mu YL, Xie YY, Zhou L, et al. Cardioprotective effect of ‘methylamine irisolidone’, a new compound, in hypoxia/reoxygenation injury in cultured rat cardiac myocytes. Chem Biodivers 2009; 6(8): 1170-7.
[http://dx.doi.org/10.1002/cbdv.200800314] [PMID: 19697334]
[60]
Yamaki K, Kim DH, Ryu N, Kim YP, Shin KH, Ohuchi K. Effects of naturally occurring isoflavones on prostaglandin E2 production. Planta Med 2002; 68(2): 97-100.
[http://dx.doi.org/10.1055/s-2002-20263] [PMID: 11859455]
[61]
Wang H, Bai X, Sun J, Kano Y, Makino T, Yuan D. Metabolism and excretion of kakkalide and its metabolites in rat urine, bile, and feces as determined by HPLC/UV and LC/MS/MS. Planta Med 2013; 79(16): 1552-7.
[http://dx.doi.org/10.1055/s-0033-1350832] [PMID: 24108437]
[62]
Bai X, Qu J, Lu J, Kano Y, Yuan D. Pharmacokinetics of kakkalide and its main metabolites in rat plasma determined by HPLC-DAD and LC–MSn. J Chromatogr B Analyt Technol Biomed Life Sci 2011; 879(5-6): 395-402.
[http://dx.doi.org/10.1016/j.jchromb.2010.12.025] [PMID: 21256817]
[63]
Zhang G, Sun J, Kano Y, Yuan D. Metabolic profile of irisolidone in rats obtained by ultra-high performance liquid chromatography/quadrupole time-of-flight mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2013; 941: 1-9.
[http://dx.doi.org/10.1016/j.jchromb.2013.09.033] [PMID: 24184829]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy